SEARCH

SEARCH BY CITATION

References

  • 1
    Lee WL. Hepatitis B virus infection. N Engl J Med 1997; 334:17331745.
  • 2
    Hoofnagle JH, Shafritz DA, Popper H. Chronic type B hepatitis and the “healthy” HBsAg carrier state. Hepatology 1987; 7:758763.MEDLINE
  • 3
    de Franchis R, D'Arminio A, Vecchi M, Ronchi G, Del Ninno E, Parravicini A, Ferroni P, et al. Chronic asymptomatic HBsAg carriers: histologic abnormalities and diagnostic and prognostic value of serologic markers of the HBV. Gastroenterology 1980; 9:521527.
  • 4
    de Franchis R, Meucci G, Vecchi M, Tatarella M, Colombo M, Del Ninno E, Rumi MG, et al. The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Inter Med 1993; 118:191194.
  • 5
    Yokosuka O, Omata M, Imazeki F, Okuda K. Active and inactive replication of hepatitis B virus deoxyribonucleic acid in chronic liver disease. Gastroenterology 1985; 89:610616.MEDLINE
  • 6
    Raimondo G, Meucci G, Sardo MA, Rodinò G, Campo S, Vecchi M, Pernice P, et al. Persistence of “wild-type” and “e-minus” hepatitis B virus infection in chronic healthy HBsAg/anti-HBe positive carriers. J Hepatol 1994; 20:148151.MEDLINE
  • 7
    Davis GL, Hoofnagle JH, Waggoner JC. Spontaneous reactivation of chronic hepatitis B virus infection. Gastroenterology 1984; 86:230235.MEDLINE
  • 8
    Perrillo RP, Campbell CR, Sanders GE, Regenstein FG, Bodicky CJ. Spontaneous clearance and reactivation of hepatitis B virus infection among male homosexuals chronic type B hepatitis. Ann Intern Med 1984; 100:4346.MEDLINE
  • 9
    Raimondo G, Rodinò G, Smedile V, Brancatelli S, Villari D, Longo G, Squadrito G. Hepatitis B virus (HBV) markers and HBV-DNA in serum and liver tissue of patients with acute exacerbation of chronic type B hepatitis. J Hepatol 1990; 10:271273.MEDLINE
  • 10
    Hoofnagle JH, Dusheiko GM, Schafer DF, Jones A, Micetich KC, Young RC. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med 1982; 96:447449.MEDLINE
  • 11
    Davis GL, Hoofnagle JH. Reactivation of chronic type B hepatitis presenting as acute viral hepatitis. Ann Intern Med 1985; 102:762765.MEDLINE
  • 12
    Lok AS, Liang RH, Chiu EK, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Gastroenterology 1991; 100:182188.MEDLINE
  • 13
    Brunetto MR, Oliveri F, Rocca G, Criscuolo D, Chiaberge E, Capalbo M, David E, et al. Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen. Hepatology 1989; 10:198202.MEDLINE
  • 14
    Brunetto MR, Oliveri F, Colombatto P, Capalbo M, Barbera C, Bonino F. Treatment of chronic anti-HBe positive hepatitis B with interferon-alpha. J Hepatol 1995; 22(Suppl 1):4244.MEDLINE
  • 15
    Diestang JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995; 333:16571661.MEDLINE
  • 16
    Honkoop P, de Man RA, Heijtink RA, Schalm SW. Hepatitis B reactivation after lamivudine. Lancet 1995; 346:11561157.MEDLINE
  • 17
    Tassopoulos NC, Volpes R, Pastore G, Heathcote J, Buti M, Goldin RD, Hawley S, et al. Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Hepatology 1999; 29:889896.MEDLINE
  • 18
    Lieberman HM, LaBrecque DR, Kew MC, Hadzyiannis SJ, Shafritz DA. Detection of hepatitis B virus directly in human serum by a simplified molecular hybridization test. Comparison to HBeAg/anti-HBe status in HBsAg carriers. Hepatology 1983; 3:285291.MEDLINE
  • 19
    Villari D, Raimondo G, Smedile V, Rodinò G, Brancatelli S, Longo G, Squadrito G, et al. Hepatitis B-DNA replication and histological patterns in liver biopsy specimens of chronic HBsAg positive patients with and without hepatitis delta virus superinfection. J Clin Pathol 1989; 42:689693.MEDLINE
  • 20
    Villari D, Pollicino T, Spinella S, Russo F, Campo S, Rodinò G, Squadrito G, et al. Hepatitis B e antigen detection in formalin-fixed liver biopsy specimens. Am J Clin Pathol 1995; 103:136140.MEDLINE
  • 21
    Pollicino T, Campo S, Raimondo G. PreS and core gene heterogeneity in hepatitis B virus (HBV) genomes isolated from patients with long-lasting HBV chronic infection. Virology 1995; 208:672677.MEDLINE
  • 22
    Pollicino T, Pernice F, Campo S, Mesiti O, Misefari V, Pernice M, Raimondo G. Severe outcome of hepatitis B virus (HBV) infection and lack of HB e antigen-defective virus emergence in patients homozygous for HLA class I alleles. J Gen Virol 1996; 77:18331836.MEDLINE
  • 23
    Schepis F, Verucchi G, Pollicino T, Attard L, Brancatelli S, Longo G, Raimondo G. Outcome of liver disease and response to interferon treatment are not influenced by hepatitis B virus core gene variability in children with chronic type B hepatitis. J Hepatol 1997; 26:765770.MEDLINE
  • 24
    Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 1999; 341:2226.MEDLINE
  • 25
    Shafritz DA, Shouval D, Sherman HI, Hadziyannis SJ, Kew MC. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. N Engl J Med 1981; 305:10671073.MEDLINE
  • 26
    Ranki M, Schatzl HM, Zachoval R, Uusi-Oukari M, Lehtovaara P. Quantification of hepatitis B virus DNA over a wide range from serum for studying viral replicative activity in response to treatment and recurrent infection. Hepatology 1995; 21:14921499.MEDLINE
  • 27
    Paterlini P, Gerken G, Nakajima E, Terre S, D'Errico A, Grigioni W, Nalpas B, et al. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med 1990; 323:8085.MEDLINE
  • 28
    Yu MC, Yuan J-M, Ross RK, Govindarajan S. Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non Asians in Los Angeles county, California. Hepatology 1997; 25:226228.MEDLINE
  • 29
    Liang TJ, Baruch Y, Ben-Porath E, Enat R, Bassan L, Brown NV, Rimon N. Hepatitis B virus infection in patients with idiopathic liver disease. Hepatology 1991; 13:10441051.MEDLINE
  • 30
    Chazouilleres O, Mamish D, Kim M, Carey K, Ferrell L, Roberts JP, Ascher NL, et al. Occult hepatitis B virus as source of infection in liver transplant recipients. Lancet 1994; 343:142146.MEDLINE
  • 31
    Wu JC, Chen PJ, Kuo MYP, Lee SD, Chen DS, Ting LP. Production of hepatitis Delta virus and suppression of helper hepatitis B virus in human hepatoma cell line. J Virol 1991; 65:10991104.MEDLINE
  • 32
    Chang CN, Skalski V, Zhou JH, Cheng Y-C. Biochemical pharmacology of (+) and (−) 2′,3′-dideoxy-3′-thiacytidine as anti-hepatitis B virus agents. J Biochem Chem 1992; 267:2241422420.
  • 33
    Grumayer ER, Panzer S, Ferenci P, Gadner H. Recurrence of hepatitis B in children with serologic evidence of past hepatitis B virus infection undergoing antileukemic chemiotherapy. J Hepatol 1989; 8:232235.MEDLINE
  • 34
    Marcellin P, Giostra E, Martinot-Peignoux M, Loriot MA, Jaegle ML, Wolf P, Degott C, et al. Redevelopment of hepatitis B surface antigen after renal transplantation. Gastroenterology 1991; 100:14321434.MEDLINE
  • 35
    Michalak TI, Pasquinelli C, Guilhot S, Chisari FV. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest 1994; 93:230239.MEDLINE
  • 36
    Penna A, Artini M, Cavalli A, Levrero M, Bertoletti A, Pilli M, Chisari FV, et al. Long-lasting memory T-cell responses following self-limited acute hepatitis B. J Clin Invest 1996; 98:11851194.MEDLINE
  • 37
    Raimondo G, Burk RD, Lieberman HM, Muschel JH, Hadziyannis SJ, Will H, Kew MC, et al. Interrupted replication of hepatitis B virus in liver tissue of HBsAg carriers with hepatocellular carcinoma. Virology 1988; 166:103112.MEDLINE
  • 38
    Raimondo G, Rodinò G, Brancatelli S, Sardo MA, Campo S, Smedile V, Villari D, et al. HBe antibody unrelated to “e minus” hepatitis B variant infection in patients with chronic type D hepatitis. J Hepatol 1991; 13(Suppl 4):S87S89.MEDLINE